For research use only
| Cat No. | ABC-TC0360 |
| Product Type | Human Uterine Cancer Cell Lines |
| Species | Human |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Cervix |
| Disease | Cervix Cancer |
| Product Code | CVCL_3379 |
HeLa-382 is a human cervical carcinoma cell line widely used in oncology, virology, and genetic studies, supporting cancer biology and therapeutic testing.
HeLa-382 is a clonal derivative of HeLa cells established for enhanced reproducibility in experimental oncology and cell signaling studies. These cells maintain stable growth kinetics and express consistent levels of biomarkers associated with cervical cancer progression. This subline has been used to study responses to DNA-damaging agents and cell cycle checkpoints, making it valuable in anti-cancer drug research and radiation biology. Its homogenous behavior ensures reproducible outcomes in high-throughput settings. The cells undergo rigorous screening and isolation procedures, and are rigorously tested to ensure they are free of contamination from HIV-1, HBV, HCV, Syphilis, Mycoplasma, Fungi, Yeast, and Bacteria.
| Product Code | CVCL_3379 |
| Species | Human |
| Cat.No | ABC-TC0360 |
| Product Category | Tumor Cell Lines |
| Size/Quantity | 1 vial |
| Shipping Info | Dry Ice |
| Growth Conditions | 37 ℃, 5% CO2 |
| Source Organ | Cervix |
| Disease | Cervix Cancer |
| Biosafety Level | 1 |
| Storage | Liquid Nitrogen |
| Product Type | Human Uterine Cancer Cell Lines |
HeLa 382 cell line is optimized for oncology research, including studies of DNA damage response, cell cycle checkpoint regulation, and response to radiation or chemotherapy. Their stable marker expression enables proteomic and transcriptomic profiling, facilitating the identification of key molecular signatures linked to treatment resistance. The cell line is suitable for high-throughput drug screening and mechanistic studies in cancer therapeutics.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
